Health System

A Tabula Rasa for pharmacy consulting

Catalyst Rx PBM expands Generic Advantage Plan.

Prostate cancer patients should not be limited to least costly therapy

Tabula Rasa Strategies to offer medication therapy management consulting services.

Covidien recalls 32 lots of its prefilled syringes containing heparin

A men's health group is organizing an online petition to urge Congress to rescind a CMS practice of restricting prostate cancer patients to the least costly drug alternative.

CVS, NCOA announce three-year extension of Prescription for Better Health Partnership

Covidien is recalling its heparin products supplied by Scientific Protein Laboratories because they contain a heparin-like contaminant.

FDA warns consumers Total Body Formula and Total Body Mega Formula recalled

CVS and National Council on Aging Extend Prescription for Better Health Partnership.

Two HIV drugs suspected of producing higher cardiovascular risk

FDA warns consumers about recall of "Total Body Formula" and "Total Body Mega Formula".

FDA studying if gel for diabetic ulcers causes cancer

FDA is looking at whether Ziagen and Videx is linked to more heart attacks.

FDA studying link between Singulair and suicides

Regranex is being studied by the FDA on whether it is linked to higher rates of cancer.

New weight-based dosing for ribavirin available for hepatitis C patients

The FDA is undertaking a study of Merck?s Singulair to see if it is associated with a higher rate of suicide.

Hospitals show that following best practices can reduce drug administration errors

Schering-Plough has announced that FDA has approved a 1,400-mg dose of ribavirin and recommended that it be dosed based on patient weight.

R.Ph.s believe patient education on insomnia is important, Takeda study shows

The results of a demonstration project involving seven Bay Area hospitals showed that they cut their medication administration errors by 57% after they followed a set of six best practices.

Pharmacist who forged Rx faces loss of license for three years

Takeda survey results show pharmacists believe more patient information about insomnia medications is necessary.

Pharmacy benefit manager launches specialty pharmacy program

A New Jersey pharmacist could be sentenced to three years of probation and a three-year suspension of his license for forging a prescription for oxycodone.

CIGNA offers generic coupons, price comparisons on its online Rx price quote tool

Prime Therapeutics introduces Triessent specialty pharmacy program

FDA advises consumers not to use Blue Steel and Hero dietary supplements

CIGNA adds online generic coupons and prescription drug price comparisons to its online prescription drug price quote tool

Calif. board puts off e-pedigree rule to 2011

FDA warns consumers not to use Blue Steel and Hero products

FDA issues draft guidance for the development of drug-eluting stents

The California Board of Pharmacy has announced that it will delay implementation of its electronic pedigree requirements until 2011.

FDA seeks comment on pedigree technologies

FDA issues draft guidelines for drug-eluting stents

MTM looks to gain traction beyond Medicare program

In a Federal Register notice, the Food & Drug Administration is seeking comments regarding prescription drug authentication

Inflammatory mass leads Medtronic to recall implantable pumps

ClearScript looks to expand its medication therapy management program to employer health plans.

Braun API supplier issues heparin bag recall

Medtronic recalls SynchroMed EL, SynchroMed II, and IsoMed implantable pumps

PhRMA joins SMARxT drug disposal cause

Scientific Protein Laboratories issues recall of heparin sodium active pharmaceutical ingredient

Supplier to physician dispensing doubles capacity at new larger facility

Another group, the Pharmaceutical Research & Manufacturers of America, is going green

Compassionate use of mifamurtide available for osteosarcoma

Bryant Ranch Prepack prescription prepacker for physicians opens larger facility

Onsite health centers not being fully tapped by companies

Mifamurtide available through compassionate access study

NCPIE survey finds that most adults use OTCs for themselves and their children

Companies not fully tapping potential of onsite health centers